Altoida raises $6.3 million in series A funding round to further AI-enabled healthcare goals
Georgia-based healthcare firm Altoida Inc has raised $6.3 million (£5m) in a series A funding round conducted by German pharmaceutical company Merck KGaA-owned capital venture firm M Ventures, with participation from Grey Sky Venture Partners, VI Partners AG, Alpana Ventures, and FYRFLY Venture Partners.
Altoida, which is led by a team of esteemed neuroscientists, physicians and computer scientists, utilises digital biomarkers to drive better clinical outcomes for brain disease....